These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 8884864)
41. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309 [TBL] [Abstract][Full Text] [Related]
42. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery. Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293 [TBL] [Abstract][Full Text] [Related]
43. CD11b may be a less satisfactory indicator for cardiac ischemia-reperfusion injury in coronary artery bypass graft surgery with cardiopulmonary bypass than cardiac troponin I. Li C; Zhao W; Wu K; Zhang J; Jia N J Clin Anesth; 2005 May; 17(3):158-62. PubMed ID: 15896579 [TBL] [Abstract][Full Text] [Related]
44. Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction. Gagnon J; Laporta D; Béïque F; Langlois Y; Morin JF Perfusion; 2010 Jul; 25(4):205-10. PubMed ID: 20605871 [TBL] [Abstract][Full Text] [Related]
45. Changes in cerebral vascular reactivity occur early during cardiopulmonary bypass in the rat. Modine T; Azzaoui R; Ouk T; Fayad G; Lacroix D; Warembourg H; Bordet R; Gourlay T Ann Thorac Surg; 2006 Aug; 82(2):672-8. PubMed ID: 16863783 [TBL] [Abstract][Full Text] [Related]
46. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559 [TBL] [Abstract][Full Text] [Related]
48. Vascular resistance during cardiopulmonary bypass. Its effect on cardiac performance in the immediate post-bypass period. Putnam EA; Manners JM Anaesthesia; 1983 Jul; 38(7):635-43. PubMed ID: 6603176 [TBL] [Abstract][Full Text] [Related]
49. Calcium Administration During Weaning From Cardiopulmonary Bypass: A Narrative Literature Review. Lomivorotov VV; Leonova EA; Belletti A; Shmyrev VA; Landoni G J Cardiothorac Vasc Anesth; 2020 Jan; 34(1):235-244. PubMed ID: 31350149 [TBL] [Abstract][Full Text] [Related]
50. Action of propofol on resistance and capacitance vessels during cardiopulmonary bypass. Baraka A; Dabbous A; Siddik S; Bijjani A Acta Anaesthesiol Scand; 1991 Aug; 35(6):545-7. PubMed ID: 1897352 [TBL] [Abstract][Full Text] [Related]
51. Low systemic vascular resistance after cardiopulmonary bypass: are we any closer to understanding the enigma? Johnson MR Crit Care Med; 1999 Jun; 27(6):1048-50. PubMed ID: 10397196 [No Abstract] [Full Text] [Related]
52. Cerebral oxygenation and vascular resistance changes during cardiopulmonary bypass - where is the proof? A reply. Sperna Weiland NH; Hollmann MW; Immink RV Anaesthesia; 2017 May; 72(5):664-665. PubMed ID: 28401548 [No Abstract] [Full Text] [Related]
53. Cerebral oxygenation and vascular resistance changes during cardiopulmonary bypass - where is the proof? Grocott HP Anaesthesia; 2017 May; 72(5):663-664. PubMed ID: 28401546 [No Abstract] [Full Text] [Related]
55. Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases. Signori D; Magliocca A; Hayashida K; Graw JA; Malhotra R; Bellani G; Berra L; Rezoagli E Intensive Care Med Exp; 2022 Jun; 10(1):28. PubMed ID: 35754072 [TBL] [Abstract][Full Text] [Related]
56. Comparative effects of propofol and nitroglycerine on efficacy of rewarming in patients undergoing on-pump coronary artery bypass grafting. Kumar B; Chauhan P; Shyam Thinganam KS Ann Card Anaesth; 2015; 18(2):145-52. PubMed ID: 25849681 [TBL] [Abstract][Full Text] [Related]
57. Effects of cardiopulmonary bypass on systemic vascular resistance. Kam PC; Hines L; O'Connor E Perfusion; 1996 Jul; 11(4):346-50. PubMed ID: 8884864 [TBL] [Abstract][Full Text] [Related]
58. Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass. Deakin CD; Dalrymple-Hay MJ; Jones P; Monro JL Eur J Cardiothorac Surg; 1998 May; 13(5):546-50. PubMed ID: 9663536 [TBL] [Abstract][Full Text] [Related]
59. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index. Yamada T; Takeda J; Katori N; Tsuzaki K; Ochiai R J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598 [TBL] [Abstract][Full Text] [Related]
60. Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery. Toikkanen V; Rinne T; Huhtala H; Laurikka J; Porkkala H; Tarkka M; Mennander A Scand J Clin Lab Invest; 2014 Jan; 74(1):37-43. PubMed ID: 24266780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]